Main Sector of relevance\IRC classification 3. Biological Sciences
3.30 Hemosorbent ANTIGLOBULIN E
Developers’ contact information
State Scientific Institution “The Institute of Bioorganic Chemistry of the National Academy of Sciences of Belarus”
220141, Minsk, Kuprevich St., 5/2
Tel./Fax:+375 (17) 267-87-61
Summary
Hemosorbent ANTIGLOBULIN E is used as a means of medical technology for selective removal of immunoglobulin E from the whole blood of a human using the method of biospecific sorption.
Description
Disposable hemosorbent in polyethylene mass-transfer circuit. The volume of hemosorbent in mass-transfer case: 25-45 ml; sorption time – 30-60 min; sorption capacity – 20-40 ME/ml; shelf life – 3 years from the production date. According to all technical features hemosorbent is up to the best world samples. There are no domestic analogs. The removal of immunoglobulin E from the whole blood of patients with allergic pathology has a marked medical effect, up to full disappearance of the disease symptoms. Therapeutic indications: bronchial asthma (of allergic and mixed types); atopic dermatitis; urticaria; allergic rhinitis; allergic tracheitis; allergic pharyngitis.
Technology type
Technical advantages and economic benefits
High-efficient synthesis technology ANTIGLOBULIN E helps to reduce the cost of hemosorbent for 5 times in comparison with foreign analogs.
Technology differentiation and uniqueness
New technology.
Context in which technology was identified
International specialized exhibition “Chemistry. Oil and gas”, 2009.
It is implemented and used in medical institutions of Belarus.
Technological keywords
ANTIGLOBULIN E, hemosorbent, allergy.
Development Stage
Intellectual property rights
Range of applications
Medicine, biological research.
Classifier Used at the EU Innovation Relay Centres
Preferable Regions
Practical experience
The technology is introduced and implemented.
Environmental impact
—
Type of collaboration sought
Terms and restrictions
—
Support provided at transfer of the technology